Literature DB >> 7262628

Chronic hepatitis type B in childhood: longitudinal study of 35 cases.

F Bortolotti, P Cadrobbi, C Crivellaro, A Bertaggia, A Alberti, G Realdi.   

Abstract

Clinical, virological, and histological features of hepatitis B virus infection have been examined in 35 children, aged 1 to 11 years, known to be hepatitis B surface antigen (HBsAg) carriers for at least six months when entering the study. Only 10 patients had a history of acute unresolved hepatitis: in the remaining cases the detection of HBsAg had been an occasional finding. Although 77% of the patients were asymptomatic, all had evidence of hepatic involvement and liver history showed the features of chronic persistent hepatitis in 18 cases and of chronic active hepatitis in 16 cases, with associated cirrhosis in two of them. One patient had only minimal histological changes. A high percentage of children with both chronic persistent and chronic active hepatitis had evidence of active virus replication throughout the observation period. During the follow-up study of one to eight years (mean 3.1 +/- 1.7 years), transaminase levels became consistently normal in five patients with chronic persistent hepatitis, and inflammatory infiltrates disappeared in three of them. However, only one of these children cleared HBsAg from serum. Eleven of 16 patients with chronic active hepatitis received immunosuppressive treatment but only one of them achieved a complete and protracted remission, although active viral replication persisted. On the other hand, two of five untreated patients reached complete remission after two and three years of follow-up respectively and one of them cleared HBsAg three years later. These results would suggest the possibility of a spontaneous complete remission of HBsAg positive chronic active hepatitis in children but also raise doubts about the usefulness of immunosuppressive therapy in such patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7262628      PMCID: PMC1419274          DOI: 10.1136/gut.22.6.499

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  Hepatitis B surface antigen in the serum of infants after deliver from asymptomatic carrier mothers.

Authors:  K Okada; T Yamada; Y Miyakawa; M Mayumi
Journal:  J Pediatr       Date:  1975-09       Impact factor: 4.406

2.  Vertical transmission of hepatitis B antigen in Taiwan.

Authors:  C E Stevens; R P Beasley; J Tsui; W C Lee
Journal:  N Engl J Med       Date:  1975-04-10       Impact factor: 91.245

3.  Infection of neonates and infants with the hepatitis B virus.

Authors:  I L Schweitzer
Journal:  Prog Med Virol       Date:  1975

4.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

5.  Papular acrodermatitis of childhood. An Australia antigen disease.

Authors:  F Gianotti
Journal:  Arch Dis Child       Date:  1973-10       Impact factor: 3.791

6.  Neonatal onset of the hepatitis-associated-antigen carrier state.

Authors:  D A Merrill; R S Dubois; P F Kohler
Journal:  N Engl J Med       Date:  1972-12-21       Impact factor: 91.245

7.  Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.

Authors:  G Realdi; A Alberti; M Rugge; F Bortolotti; A M Rigoli; F Tremolada; A Ruol
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

8.  DNA polymerase associated with human hepatitis B antigen.

Authors:  P M Kaplan; R L Greenman; J L Gerin; R H Purcell; W S Robinson
Journal:  J Virol       Date:  1973-11       Impact factor: 5.103

9.  Immune response to hepatitis B virus in children with papular acrodermatitis.

Authors:  M Colombo; M A Gerber; S J Vernace; F Gianotti; F Paronetto
Journal:  Gastroenterology       Date:  1977-11       Impact factor: 22.682

10.  Infection with hepatitis B virus in infancy. A longitudinal study of 8 cases.

Authors:  P Skinhøj
Journal:  Arch Dis Child       Date:  1978-09       Impact factor: 3.791

View more
  7 in total

1.  Portal hypertension in north Indian children.

Authors:  N K Arora; R Lodha; S Gulati; A K Gupta; P Mathur; M S Joshi; N Arora; D K Mitra
Journal:  Indian J Pediatr       Date:  1998 Jul-Aug       Impact factor: 1.967

2.  Serological and histological follow up of chronic hepatitis B infection.

Authors:  M Ruiz-Moreno; T Camps; J G Aguado; J C Porres; H Oliva; J Bartolomé; V Carreño
Journal:  Arch Dis Child       Date:  1989-08       Impact factor: 3.791

3.  Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas.

Authors:  W J Edmunds; G F Medley; D J Nokes; C J O'Callaghan; H C Whittle; A J Hall
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

Review 4.  Natural history of the HBsAg carrier.

Authors:  M G Anderson; I M Murray-Lyon
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

5.  Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection.

Authors:  L C Da Silva; C L Madruga; F J Carrilho; J R Pinho; A Saéz-Alquezar; C Santos; L Bassit; C Barreto; L E Fonseca; V A Alves; R Leitão; R Vianna; R A Cardoso; A V França; L C Gayotto
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

6.  A 7 year survey of acute hepatitis type B.

Authors:  F Bortolotti; P Cadrobbi; A Bertaggia; L Rude; A Alberti; G Realdi
Journal:  Arch Dis Child       Date:  1983-12       Impact factor: 3.791

7.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.